Discontinued — last reported Q4 '25
Johnson & Johnson Investing Cash Flow increased by 97.0% to -$542.00M in Q3 2025 compared to the prior quarter. Year-over-year, this metric grew by 82.7%, from -$3.13B to -$542.00M.
A large negative value is typical for growing companies, indicating they are spending more on assets and acquisitions than they are receiving from sales.
The aggregate net change in cash resulting from all investing activities, including capital expenditures, business acqui...
For tech giants, this is often the largest area of cash outflow after shareholder returns, driven by data center expansion.
cf_net_cash_from_investing| Q2 '21 | Q2 '22 | Q2 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Value | -$185.00M | -$3.63B | $3.32B | -$464.00M | -$13.69B | -$3.13B | -$1.32B | -$297.00M | -$18.26B | -$542.00M |
| QoQ Change | — | <-999% | +191.2% | -114.0% | <-999% | +77.1% | +57.8% | +77.5% | <-999% | +97.0% |
| YoY Change | — | <-999% | +191.2% | — | -512.9% | — | — | +36.0% | -33.4% | +82.7% |
We use cookies for analytics. See our Privacy and Cookie Policy.